Using a method called CUT&RUN, researchers saw that Zelda binds genes that decide wing shape, vein placement, and cell ...

After inking an USD 8.4 billion deal with BMS, the founder says Biokin’s next chapter is about efficiency, innovation, and ...

Singh Biotechnology is advancing a novel class of cell-penetrating nano-antibodies that unlock intracellular targets once ...

A recognition of its strong market presence, global footprint and commitment to sustainable practices ...